DK165584D0 - (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinoliner og dermed beslaegtede forbindelser - Google Patents

(1h-tetrazol-5-yl)tetrazolo(1,5-a)quinoliner og dermed beslaegtede forbindelser

Info

Publication number
DK165584D0
DK165584D0 DK1655/84A DK165584A DK165584D0 DK 165584 D0 DK165584 D0 DK 165584D0 DK 1655/84 A DK1655/84 A DK 1655/84A DK 165584 A DK165584 A DK 165584A DK 165584 D0 DK165584 D0 DK 165584D0
Authority
DK
Denmark
Prior art keywords
tetrazolo
quinolines
tetrazol
related compounds
compounds
Prior art date
Application number
DK1655/84A
Other languages
English (en)
Other versions
DK165694C (da
DK165694B (da
DK165584A (da
Inventor
Terry L Wright
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK165584D0 publication Critical patent/DK165584D0/da
Publication of DK165584A publication Critical patent/DK165584A/da
Publication of DK165694B publication Critical patent/DK165694B/da
Application granted granted Critical
Publication of DK165694C publication Critical patent/DK165694C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
DK165584A 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-tetrazolo-(iso)quinoliner eller -oe1,8aanaphthyridiner eller et pharmaceutisk acceptabelt salt deraf DK165694C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/478,964 US4496569A (en) 1983-03-25 1983-03-25 Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof
US47896483 1983-03-25

Publications (4)

Publication Number Publication Date
DK165584D0 true DK165584D0 (da) 1984-03-23
DK165584A DK165584A (da) 1984-09-26
DK165694B DK165694B (da) 1993-01-04
DK165694C DK165694C (da) 1993-06-07

Family

ID=23902115

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165584A DK165694C (da) 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-tetrazolo-(iso)quinoliner eller -oe1,8aanaphthyridiner eller et pharmaceutisk acceptabelt salt deraf

Country Status (19)

Country Link
US (1) US4496569A (da)
EP (1) EP0120484B1 (da)
JP (1) JPS59176287A (da)
KR (1) KR900003649B1 (da)
AT (1) ATE26717T1 (da)
AU (1) AU558762B2 (da)
CA (1) CA1252100A (da)
DE (1) DE3463271D1 (da)
DK (1) DK165694C (da)
ES (1) ES530876A0 (da)
GR (1) GR81463B (da)
IE (1) IE57072B1 (da)
IL (1) IL71318A (da)
MX (1) MX9203341A (da)
NO (1) NO161067C (da)
NZ (1) NZ207582A (da)
PH (1) PH20353A (da)
PT (1) PT78288B (da)
ZA (1) ZA842067B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014171A1 (de) * 1990-05-03 1991-11-07 Basf Ag Cyanochinolinverbindungen
CA2184694A1 (en) * 1994-03-25 1995-10-05 Kay K. Olmstead Process for preparing (1h-tetrazol-5-yl)tetrazolo [1,5-a] quinolines andnaphthyridines
JP3674407B2 (ja) 1999-09-21 2005-07-20 ヤマハ株式会社 演奏データ編集装置、方法及び記録媒体
US7358259B2 (en) 2003-09-26 2008-04-15 Rigel Pharmaceuticals, Inc. HCV inhibitors and methods of using them
US7569580B2 (en) 2004-06-03 2009-08-04 Rigel Pharmaceuticals, Inc. Heterotricyclic compounds for use as HCV inhibitors
KR101101950B1 (ko) * 2011-11-04 2012-01-02 이동진 왕복 페달식 자전거

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764681A (en) * 1970-07-08 1973-10-09 Lilly Co Eli Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds

Also Published As

Publication number Publication date
NZ207582A (en) 1986-10-08
EP0120484B1 (en) 1987-04-22
AU2595384A (en) 1984-09-27
CA1252100A (en) 1989-04-04
PH20353A (en) 1986-12-04
JPH0415791B2 (da) 1992-03-19
ATE26717T1 (de) 1987-05-15
IE840719L (en) 1984-09-25
PT78288A (en) 1984-04-01
ES8601970A1 (es) 1985-11-01
DE3463271D1 (en) 1987-05-27
KR840008156A (ko) 1984-12-13
DK165694C (da) 1993-06-07
NO841156L (no) 1984-09-26
PT78288B (en) 1986-04-22
KR900003649B1 (ko) 1990-05-28
NO161067C (no) 1989-06-28
GR81463B (da) 1984-12-11
JPS59176287A (ja) 1984-10-05
IE57072B1 (en) 1992-04-22
US4496569A (en) 1985-01-29
MX9203341A (es) 1992-08-01
EP0120484A1 (en) 1984-10-03
ES530876A0 (es) 1985-11-01
DK165694B (da) 1993-01-04
ZA842067B (en) 1984-10-31
DK165584A (da) 1984-09-26
AU558762B2 (en) 1987-02-05
NO161067B (no) 1989-03-20
IL71318A (en) 1986-11-30
IL71318A0 (en) 1984-06-29

Similar Documents

Publication Publication Date Title
DE3868308D1 (de) Heterozyklische derivate, verfahren zu deren herstellung und diese enthaltende radiosensibilisierende agenzien und antivirale agenzien.
DE3851932T2 (de) Mehrzweckfassung.
NL971041I1 (nl) Stikstofbevattende, heterocyclische verbindingen, hun bereiding en gebruik.
DE3884055T2 (de) (1H-Azol-1-ylmethyl)-substituierte Benzotriazol-Derivate.
GR890100410A (el) Παραγωγα βενζαζεπινης και βενζοθειαζεπινης.
PT78289A (en) (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds
DK165584D0 (da) (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinoliner og dermed beslaegtede forbindelser
FI834665A (fi) Imidazo(1,5- a)pyridin-derivat.
IE831145L (en) Pyridine derivatives
ATE41003T1 (de) Tetrazolothienopyridine.
DE3880991T2 (de) Aminoanthracendion-bis-platinkomplexe, nützlich als Antitumor-Agenzien.
ATE50449T1 (de) (tetrazolyl)thienopyridone.
SE8400118D0 (sv) Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
DE68912159D1 (de) Dioxoquinazolinderivat enthaltendes Antihypertensivum.
DK69886A (da) Substituerede phenoxypropylthiopyrazolo(1,5-a)pyridin- eller -benzimidazolderivater, fremgangsmaade til fremstilling deraf og antiallergisk middel indeholdende saadanne forbindelser
ATE58834T1 (de) Phenylchinolinsaeure und derivate als antitumormittel.
ATE84794T1 (de) Aminosaeure-derivate als antihypertensive.

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed